Skip to content
healthcare.dev

Carafate

NDC 58914-170, Sucralfate, suspension, from Allergan, Inc..

Product NDC
58914-170
Status
Listed
Labeler
Allergan, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA019183
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58914-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SUCRALFATE1 g/10mL

Pharmacologic classes

Aluminum Complex [EPC]; Organometallic Compounds [CS]

Package NDCNDC-11Package
58914-170-1458914017014420 mL in 1 BOTTLE (58914-170-14)
58914-170-60589140170606 CUP, UNIT-DOSE in 1 BOX (58914-170-60) / 10 mL in 1 CUP, UNIT-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0fb67b1c-b4c0-46f2-8a81-df1510e006aa

Use it

Look up 58914-170 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58914-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58914-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.